Jump to main content.

Oral Dosage Form New Animal Drugs; Oxibendazole Paste

Note: EPA no longer updates this information, but it may be useful as a reference or resource.

 [Federal Register: June 8, 2006 (Volume 71, Number 110)]
[Rules and Regulations]
[Page 33236-33237]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08jn06-11]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 520

Oral Dosage Form New Animal Drugs; Oxibendazole Paste

AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
drug regulations to reflect approval of a supplemental new animal drug 
application (NADA) filed by Pfizer, Inc. The supplemental NADA provides 
for revised food safety labeling for oxibendazole paste administered 
orally to horses as an antiparasitic.

DATES: This rule is effective June 8, 2006.

FOR FURTHER INFORMATION CONTACT: Melanie R. Berson, Center for 
Veterinary Medicine (HFV-110), Food and Drug Administration, 7500 
Standish Pl., Rockville, MD 20855, 301-827-7540, e-mail: 
melanie.berson@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: Pfizer, Inc., 235 East 42d St., New York, NY 
10017-5755, filed a supplement to NADA 121-042 for use of ANTHELCIDE EQ 
(oxibendazole) Paste administered orally to horses as an antiparasitic. 
The supplemental NADA provides for revised food safety labeling. The 
supplemental NADA is approved as of April 12, 2006, and the regulations 
are amended in 21 CFR 520.1638 to reflect the approval.

[[Page 33237]]

    Approval of this supplemental NADA did not require review of 
additional safety or effectiveness data or information. Therefore, a 
freedom of information summary is not required.
    The agency has determined under 21 CFR 25.33(d)(1) that this action 
is of a type that does not individually or cumulatively have a 
significant effect on the human environment. Therefore, neither an 
environmental assessment nor an environmental impact statement is required.
    This rule does not meet the definition of ``rule'' in 5 U.S.C. 
804(3)(A) because it is a rule of ``particular applicability.'' 
Therefore, it is not subject to the congressional review requirements 
in 5 U.S.C. 801-808.

List of Subjects in 21 CFR Part 520

    Animal drugs.

? Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
authority delegated to the Commissioner of Food and Drugs and 
redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is 
amended as follows:

PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS

? 1. The authority citation for 21 CFR part 520 continues to read as 
follows:

    Authority: 21 U.S.C. 360b.

Sec.  520.1638  [Amended]

? 2. In paragraph (c)(3) of Sec.  520.1638, remove ``Not for use in 
horses intended for food.'' and add in its place ``Not for use in 
horses intended for human consumption.''

    Dated: May 26, 2006.
Steven D. Vaughn,
Director, Office of New Animal Drug Evaluation, Center for Veterinary 
Medicine.
[FR Doc. E6-8894 Filed 6-7-06; 8:45 am]
BILLING CODE 4160-01-S

 
 

Local Navigation

Jump to main content.